Neurology Grand Rounds

Progress in Blood-Based Biomarkers for Alzheimer’s Disease: Opportunities and Pitfalls

Gil Rabinovici, MD
Professor of Neurology, 
UCSF Weill Institute for Neurosciences

Jalayne Arias, JD
Assistant Professor of Neurology,
UCSF Weill Institute for Neurosciences 
Atlantic Fellow at GBHI                                                                                                     

At the end of the presentation, attendees will be able to:

  • Describe how blood-based biomarkers capture key elements of Alzheimer’s disease (AD) pathophysiology
  • Identify appropriate and inappropriate scenarios for clinical use of AD biomarkers
  • Evaluate the potential ethical and legal challenges associated with blood biomarkers

Dial-In Information

The Zoom link will be sent to the Department of Neurology via email prior to this event.

Wednesday, March 10 at 4:00pm to 5:00pm

Virtual Event
Event Type

Research & Academia

Affiliation

School of Medicine

Audience

Postdocs, Faculty

Location

Online

Department/Group
Department of Neurology
Contact Info

karl.kanner@ucsf.edu

Subscribe